ArticleJournal for immunotherapy of cancer2020

Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2

Jiangying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.